Cubist Systematic Strategies »

Rapt Therapeutics shares owned by Cubist Systematic Strategies

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Cubist Systematic Strategies from 13F filings

Historical chart of Cubist Systematic Strategies investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Cubist Systematic Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Cubist Systematic Strategies

Quarter filed Position value Share count Share price at filing
2024-09-30 $112k 56k 2.01
2024-06-30 $901k 295k 3.05
2024-03-31 $286k 32k 8.98
2023-12-31 $66k 2.7k 24.85
2023-03-31 $144k 7.8k 18.35
2021-12-31 $328k 8.9k 36.72
2021-09-30 $549k 18k 31.02

More positions owned by Cubist Systematic Strategies

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Netflix (NFLX)
Microsoft Corporation (MSFT)
Super Micro Computer Call Option (SMCI)
General Motors Company (GM)
Spotify Technology S A SHS (SPOT)
Meta Platforms Cl A (META)
Micron Technology Call Option (MU)
Arm Holdings Sponsored Ads Call Option (ARM)
Intel Corporation Call Option (INTC)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Snowflake Cl A (SNOW)
Tesla Motors Call Option (TSLA)

View all positions for Cubist Systematic Strategies

Top funds holding Rapt Therapeutics

Vanguard Group
Column Group
BlackRock
BlackRock
Kingdon Capital Management
Morgan Stanley
D. E. Shaw & Co
Acadian Asset Management
Federated Investors
Two Sigma Advisers
Geode Capital Management
State Street Corporation
Euclidean Capital
Two Sigma Investments
Alphabet

View all funds holding Rapt Therapeutics